{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:53:32Z","timestamp":1787961212140,"version":"build-2784847793"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["11A5621N"],"award-info":[{"award-number":["11A5621N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1801110N"],"award-info":[{"award-number":["1801110N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00467-021-05126-4","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T07:10:12Z","timestamp":1622272212000},"page":"1231-1243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Sickle cell nephropathy: insights into the pediatric population"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5076-9983","authenticated-orcid":false,"given":"Oyindamola C.","family":"Adebayo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3917-6727","authenticated-orcid":false,"given":"Lambertus P.","family":"Van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasiu A.","family":"Olowu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8352-7312","authenticated-orcid":false,"given":"Elena N.","family":"Levtchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5052-9274","authenticated-orcid":false,"given":"Veerle","family":"Labarque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,29]]},"reference":[{"key":"5126_CR1","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1016\/S2352-3026(14)00007-6","volume":"1","author":"B Ranque","year":"2014","unstructured":"Ranque B, Menet A, Diop IB, Thiam MM, Diallo D, Diop S, Diagne I, Sanogo I, Kingue S, Chelo D, Wamba G, Diarra M, Anzouan JB, N\u2019Guetta R, Diakite CO, Traore Y, Legueun G, Deme-Ly I, BelingaS Boidy K, Kamara I, Tharaux PL, Jouven X (2014) Early renal damage in patients with sickle cell disease in sub-Saharan Africa: a multinational, prospective, cross-sectional study. Lancet Haematol 1:e64\u2013e73","journal-title":"Lancet Haematol"},{"key":"5126_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","volume":"381","author":"FB Piel","year":"2013","unstructured":"Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M, Temperley WH, Williams TN, Weatherall DJ, Hay SI (2013) Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet 381:142\u2013151","journal-title":"Lancet"},{"key":"5126_CR3","first-page":"1","volume":"4","author":"GJ Kato","year":"2018","unstructured":"Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene- Frempong K, Krishnamurti L, Smith WR, Panepinto JA, Weatherall DJ, Costa FF, Vichinsky EP (2018) Sickle cell disease. Nat Rev Dis Prim 4:1\u201322","journal-title":"Nat Rev Dis Prim"},{"key":"5126_CR4","doi-asserted-by":"crossref","unstructured":"Taylor C, Kasztan M, Tao B, Pollock JS, Pollock DM\u00a0(2019) Combined hydroxyurea and ETA receptor blockade reduces renal injury in the humanized sickle cell mouse. Acta Physiol 225:e13178","DOI":"10.1111\/apha.13178"},{"key":"5126_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1182\/asheducation-2017.1.435","volume":"2017","author":"E Vichinsky","year":"2017","unstructured":"Vichinsky E (2017) Chronic organ failure in adult sickle cell disease. Hematology 2017:435\u2013439","journal-title":"Hematology"},{"key":"5126_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12878-017-0079-7","volume":"17","author":"AM Andong","year":"2017","unstructured":"Andong AM, Ngouadjeu EDT, Bekolo CE, Verla VS, Nebongo D, Mboue-Djieka Y, Choukem SP (2017) Chronic complications and quality of life of patients living with sickle cell disease and receiving care in three hospitals in Cameroon: a cross-sectional study. BMC Hematol 17:7","journal-title":"BMC Hematol"},{"key":"5126_CR7","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2014-02-557439","volume":"123","author":"CC Sharpe","year":"2014","unstructured":"Sharpe CC, Thein SL (2014) How I treat renal complications in sickle cell disease. Blood 123:3720\u20133726","journal-title":"Blood"},{"key":"5126_CR8","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00467-017-3650-3","volume":"32","author":"C Mammen","year":"2017","unstructured":"Mammen C, Bissonnette ML, Matsell DG (2017) Acute kidney injury in children with sickle cell disease\u2014compounding a chronic problem. Pediatr Nephrol 32:1287\u20131291","journal-title":"Pediatr Nephrol"},{"key":"5126_CR9","doi-asserted-by":"publisher","first-page":"791498","DOI":"10.1155\/2015\/791498","volume":"2015","author":"AS Adewoyin","year":"2015","unstructured":"Adewoyin AS (2015) Management of sickle cell disease: a review for physician education in Nigeria (sub-Saharan Africa). Anemia 2015:791498","journal-title":"Anemia"},{"key":"5126_CR10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1136\/bmj.1.4857.290","volume":"1","author":"AC Allison","year":"1954","unstructured":"Allison AC (1954) Protection afforded by sickle-cell trait against subtertian malarial infection. Br Med J 1:290\u2013294","journal-title":"Br Med J"},{"key":"5126_CR11","doi-asserted-by":"publisher","first-page":"e2012065","DOI":"10.4084\/mjhid.2012.065","volume":"4","author":"L Luzzatto","year":"2012","unstructured":"Luzzatto L (2012) Sickle cell anaemia and malaria. Mediterr J Hematol Infect Dis 4:e2012065","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"5126_CR12","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2471\/BLT.06.036673","volume":"86","author":"B Modell","year":"2008","unstructured":"Modell B, Darlison M (2008) Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 86:480\u2013487","journal-title":"Bull World Health Organ"},{"key":"5126_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1681\/ASN.V101187","volume":"10","author":"P Saborio","year":"1999","unstructured":"Saborio P, Scheinman JI (1999) Sickle cell nephropathy. J Am Soc Nephrol 10:187\u2013192","journal-title":"J Am Soc Nephrol"},{"key":"5126_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000494581","volume":"47","author":"KO Olaniran","year":"2019","unstructured":"Olaniran KO, Eneanya D, Nigwekar SU (2019) Sickle cell nephropathy in the pediatric population. Blood Purif 47:205\u2013213","journal-title":"Blood Purif"},{"key":"5126_CR15","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1046\/j.1523-1755.2002.00363.x","volume":"61","author":"DE Wesson","year":"2002","unstructured":"Wesson DE (2002) The initiation and progression of sickle cell nephropathy. Kidney Int 61:2277\u20132286","journal-title":"Kidney Int"},{"key":"5126_CR16","doi-asserted-by":"crossref","unstructured":"Brewin J, Tewari S, Hannemann A, Al Balushi H, Sharpe C, Gibson JS, Rees DC (2017) Early markers of sickle nephropathy in children with sickle cell anemia are associated with red cell cation transport activity. HemaSphere 1:e2","DOI":"10.1097\/HS9.0000000000000002"},{"key":"5126_CR17","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00467-019-04237-3","volume":"34","author":"RS Zahr","year":"2019","unstructured":"Zahr RS, Yee ME, Weaver J, Twombley K, Matar RB, Aviles D, Sreedharan R, Rheault MN, Malatesta-Muncher R, Stone H, Srivastava T, Kapur G, Baddi P, Volovelsky O, Pelletier J, Gbadegesin R, Seeherunvong W, Patel HP, Greenbaum LA (2019) Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol 34:1435\u20131445","journal-title":"Pediatr Nephrol"},{"key":"5126_CR18","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1681\/ASN.2011101019","volume":"23","author":"KA Nath","year":"2012","unstructured":"Nath KA, Katusic ZS (2012) Vasculature and kidney complications in sickle cell disease. J Am Soc Nephrol 23:781\u2013784","journal-title":"J Am Soc Nephrol"},{"key":"5126_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1365-2141.2011.08853.x","volume":"155","author":"CC Sharpe","year":"2011","unstructured":"Sharpe CC, Thein SL (2011) Sickle cell nephropathy - a practical approach. Br J Haematol 155:287\u2013297","journal-title":"Br J Haematol"},{"key":"5126_CR20","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s00467-010-1736-2","volume":"26","author":"AM Becker","year":"2011","unstructured":"Becker AM (2011) Sickle cell nephropathy: challenging the conventional wisdom. Pediatr Nephrol 26:2099\u20132109","journal-title":"Pediatr Nephrol"},{"key":"5126_CR21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41581-019-0181-0","volume":"15","author":"K Van Avondt","year":"2019","unstructured":"Van Avondt K, Nur E, Zeerleder S (2019) Mechanisms of haemolysis-induced kidney injury. Nat Rev Nephrol 15:671\u2013692","journal-title":"Nat Rev Nephrol"},{"key":"5126_CR22","doi-asserted-by":"publisher","first-page":"C733","DOI":"10.1152\/ajpcell.00021.2017","volume":"312","author":"ML Eshbach","year":"2017","unstructured":"Eshbach ML, Kaur A, Rbaibi Y, Tejero J, Weisz OA (2017) Hemoglobin inhibits albumin uptake by proximal tubule cells: Implications for sickle cell disease. Am J Phys Cell Physiol 312:C733\u2013C740","journal-title":"Am J Phys Cell Physiol"},{"key":"5126_CR23","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/path.5011","volume":"244","author":"A Rubio-Navarro","year":"2018","unstructured":"Rubio-Navarro A, Sanchez-Ni\u00f1o MD, Guerrero-Hue M, Garc\u00eda-Caballero C, Guti\u00e9rrez E, Yuste C, Sevillano \u00c1, Praga M, Egea J, Rom\u00e1n E, Cannata P, Ortega R, Cortegano I, de Andr\u00e9s B, Gaspar ML, Cadenas S, Ortiz A, Egido J, Moreno JA (2018) Podocytes are new cellular targets of haemoglobin-mediated renal damage. J Pathol 244:296\u2013310","journal-title":"J Pathol"},{"key":"5126_CR24","doi-asserted-by":"crossref","unstructured":"Inusa BPD, Mariachiara L, Giovanni P, Ataga KI (2018) Sickle cell nephropathy: current understanding of the presentation, diagnostic and therapeutic challenges. In: Hematology- Latest Research and Clinical Advances. pp 156\u2013185","DOI":"10.5772\/intechopen.76588"},{"key":"5126_CR25","doi-asserted-by":"crossref","unstructured":"Ataga KI, Derebail VK, Caughey M, Elsherif L, Shen JH, Jones SK, Maitra P, Pollock DM, Cai J,\u00a0Archer DR, Hinderliter AL\u00a0(2016) Albuminuria is associated with endothelial dysfunction and elevated plasma endothelin-1 in sickle cell anemia. PLoS One 11:e0162652","DOI":"10.1371\/journal.pone.0162652"},{"key":"5126_CR26","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3324\/haematol.2015.124875","volume":"100","author":"SL Saraf","year":"2015","unstructured":"Saraf SL, Zhang X, Shah B, Kanias T, Gudehithlu KP, Kittles R, Machado RF, Arruda JAL, Gladwin MT, Singh AK, Gordeuk VR (2015) Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy. Haematologica 100:1275\u20131284","journal-title":"Haematologica"},{"key":"5126_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","volume":"14","author":"P Sundd","year":"2019","unstructured":"Sundd P, Gladwin MT, Novelli EM (2019) Pathophysiology of sickle cell disease. Annu Rev Pathol Mech Dis 14:263\u2013292","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"5126_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrneph.2015.8","volume":"11","author":"KA Nath","year":"2015","unstructured":"Nath KA, Hebbel RP (2015) Sickle cell disease: renal manifestations and mechanisms. Nat Rev Nephrol 11:161\u2013171","journal-title":"Nat Rev Nephrol"},{"key":"5126_CR29","doi-asserted-by":"publisher","first-page":"F906","DOI":"10.1152\/ajprenal.00432.2017","volume":"314","author":"KA Nath","year":"2018","unstructured":"Nath KA, Belcher JD, Nath MC, Grande JP, Croatt AJ, Ackerman AW, Katusic ZS, Vercellotti GM (2018) Role of TLR4 signaling in the nephrotoxicity of heme and heme proteins. Am J Physiol Ren Physiol 314:F906\u2013F914","journal-title":"Am J Physiol Ren Physiol"},{"key":"5126_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","volume":"123","author":"JD Belcher","year":"2014","unstructured":"Belcher JD, Chen C, Nguyen J, Milbauer L, Abdulla F, Alayash AI, Smith A, Nath KA, Hebbel RP, Vercellotti GM (2014) Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood 123:377\u2013390","journal-title":"Blood"},{"key":"5126_CR31","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.1172\/JCI64578","volume":"123","author":"S Ghosh","year":"2013","unstructured":"Ghosh S, Adisa OA, Chappa P, Tan F, Jackson KA, Archer DR, Ofori-Acquah SF (2013) Extracellular hemin crisis triggers acute chest syndrome in sickle mice. J Clin Invest 123:4809\u20134820","journal-title":"J Clin Invest"},{"key":"5126_CR32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/ki.1975.54","volume":"7","author":"GA Alleyne","year":"1975","unstructured":"Alleyne GA (1975) The kidney in sickle cell anemia. Kidney Int 7:371\u2013379","journal-title":"Kidney Int"},{"key":"5126_CR33","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00277-011-1327-8","volume":"90","author":"GB Da Silva Junior","year":"2011","unstructured":"Da Silva Junior GB, Lib\u00f3rio AB, De Francesco DE (2011) New insights on pathophysiology, clinical manifestations, diagnosis, and treatment of sickle cell nephropathy. Ann Hematol 90:1371\u20131379","journal-title":"Ann Hematol"},{"key":"5126_CR34","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/0009-8981(70)90305-0","volume":"27","author":"LW Statius Van Eps","year":"1970","unstructured":"Statius Van Eps LW, Schouten H, Ter Haar Romeny-Wachter CC, La Porte-Wijsman LW (1970) The relation between age and renal concentrating capacity in sickle cell disease and hemoglobin C disease. Clin Chim Acta 27:501\u2013511","journal-title":"Clin Chim Acta"},{"key":"5126_CR35","first-page":"908","volume-title":"Pediatric Nephrology","author":"J Scheinman","year":"1994","unstructured":"Scheinman J (1994) Sickle cell nephrology. In: Holliday M, Barratt T, Avner E (eds) Pediatric Nephrology. Williams & Wilkins, Baltimore, pp 908\u2013914"},{"key":"5126_CR36","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/pbc.25188","volume":"61","author":"VMS Raj","year":"2014","unstructured":"Raj VMS, Freundlich M, Hamideh D, Alvarez O, Seeherunvong W, Abitbol C, Katsoufis C, Chandar J, Ruiz P, Zilleruelo G (2014) Abnormalities in renal tubular phosphate handling in children with sickle cell disease. Pediatr Blood Cancer 61:2267\u20132270","journal-title":"Pediatr Blood Cancer"},{"key":"5126_CR37","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/ndt\/gfm858","volume":"23","author":"O Marsenic","year":"2008","unstructured":"Marsenic O, Couloures KG, Wiley JM (2008) Proteinuria in children with sickle cell disease. Nephrol Dial Transplant 23:715\u2013720","journal-title":"Nephrol Dial Transplant"},{"key":"5126_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2165\/00128072-200204010-00004","volume":"4","author":"LDS Feltran","year":"2002","unstructured":"Feltran LDS, Carvalhaes JTDA, Sesso R (2002) Renal complications of sickle cell disease: managing for optimal outcomes. Pediatr Drugs 4:29\u201336","journal-title":"Pediatr Drugs"},{"key":"5126_CR39","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s11255-018-1803-3","volume":"50","author":"E Hariri","year":"2018","unstructured":"Hariri E, Mansour A, El Alam A, Daaboul Y, Korjian S, Aoun Bahous S (2018) Sickle cell nephropathy: an update on pathophysiology, diagnosis, and treatment. Int Urol Nephrol 50:1075\u20131083","journal-title":"Int Urol Nephrol"},{"key":"5126_CR40","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","volume":"377","author":"WC Wang","year":"2011","unstructured":"Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, Rana S, Thornburg CD, Rogers ZR, Kalpatthi RV, Barredo JC, Brown RC, Sarnaik SA, Howard TH, Wynn LW, Kutlar A, Armstrong FD, Files BA, Goldsmith JC, Waclawiw MA, Huang X, Thompson BW (2011) Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet 377:1663\u20131672","journal-title":"Lancet"},{"key":"5126_CR41","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/apa.13784","volume":"106","author":"MN Aloni","year":"2017","unstructured":"Aloni MN, Ngiyulu RM, Ekulu PM, Mbutiwi FIN, Makulo JR, Gini-Ehungu JL, Nseka NM, Lepira FB (2017) Glomerular hyperfiltration is strongly correlated with age in Congolese children with sickle cell anaemia. Acta Paediatr Int J Paediatr 106:819\u2013824","journal-title":"Acta Paediatr Int J Paediatr"},{"key":"5126_CR42","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/ckj\/sfx058","volume":"10","author":"MN Aloni","year":"2017","unstructured":"Aloni MN, Mabidi JLL, Ngiyulu RM, Ekulu PM, Mbutiwi FI, Makulo JR, Sumaili EK, Gini-Ehungu JL, Nsibu CN, Nseka NM, Lepira FB (2017) Prevalence and determinants of microalbuminuria in children suffering from sickle cell anemia in steady state. Clin Kidney J 10:479\u2013486","journal-title":"Clin Kidney J"},{"key":"5126_CR43","first-page":"407","volume":"70","author":"J Bernstein","year":"1960","unstructured":"Bernstein J, Whitten C (1960) A histologic appraisal of the kidney in sickle cell anemia. Arch Pathol 70:407\u2013418","journal-title":"Arch Pathol"},{"key":"5126_CR44","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1681\/ASN.V1111241","volume":"1","author":"DB Bhathena","year":"1991","unstructured":"Bhathena DB, Sondheimer JH (1991) The glomerulopathy of homozygous sickle hemoglobin (SS) disease: morphology and pathogenesis. J Am Soc Nephrol 1:1241\u20131252","journal-title":"J Am Soc Nephrol"},{"key":"5126_CR45","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/0009-8981(67)90222-7","volume":"17","author":"LWS Van Eps","year":"1967","unstructured":"Van Eps LWS, Schouten H, La Porte-Wijsman LW, Struyker Boudier AM (1967) The influence of red blood cell transfusions on the hyposthenuria and renal hemodynamics of sickle cell anemia. Clin Chim Acta 17:449\u2013461","journal-title":"Clin Chim Acta"},{"key":"5126_CR46","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s004670050491","volume":"12","author":"VR Dharnidharka","year":"1998","unstructured":"Dharnidharka VR, Dabbagh S, Atiyeh B, Simpson P, Sarnaik S (1998) Prevalence of microalbuminuria in children with sickle cell disease. Pediatr Nephrol 12:475\u2013478","journal-title":"Pediatr Nephrol"},{"key":"5126_CR47","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/ki.1996.109","volume":"49","author":"A Guasch","year":"1996","unstructured":"Guasch A, Cua M, Mitch WE (1996) Early detection and the course of glomerular injury in patients with sickle cell anemia. Kidney Int 49:786\u2013791","journal-title":"Kidney Int"},{"key":"5126_CR48","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00043426-200208000-00013","volume":"24","author":"PG McBurney","year":"2002","unstructured":"McBurney PG, Hanevold CD, Hernandez CM, Waller JL, McKie KM (2002) Risk factors for microalbuminuria in children with sickle cell anemia. J Pediatr Hematol Oncol 24:473\u2013477","journal-title":"J Pediatr Hematol Oncol"},{"key":"5126_CR49","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/ki.1997.116","volume":"51","author":"A Guasch","year":"1997","unstructured":"Guasch A, Cua M, You W, Mitch WE (1997) Sickle cell anemia causes a distinct pattern of glomerular dysfunction. Kidney Int 51:826\u2013833","journal-title":"Kidney Int"},{"key":"5126_CR50","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3324\/haematol.2011.050336","volume":"97","author":"TG Day","year":"2012","unstructured":"Day TG, Drasar ER, Fulford T, Sharpe CC, Thein SL (2012) Association between hemolysis and albuminuria in adults with sickle cell anemia. Haematologica 97:201\u2013205","journal-title":"Haematologica"},{"key":"5126_CR51","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2215\/CJN.03940415","volume":"11","author":"P Drawz","year":"2016","unstructured":"Drawz P, Ayyappan S, Nouraie M, Saraf S, Gordeuk V, Hostetter T, Gladwin MT, Little J, (, (2016) Kidney disease among patients with sickle cell disease, hemoglobin SS and SC. Clin J Am Soc Nephrol 11:207\u2013215","journal-title":"Clin J Am Soc Nephrol"},{"key":"5126_CR52","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000167444","volume":"7","author":"AA Bakir","year":"1987","unstructured":"Bakir AA, Hathiwala SC, Ainis H, Hryhorczuk DO, Rhee HL, Levy PS, Dunear G (1987) Prognosis of the nephrotic syndrome in sickle glomerulopathy. Am J Nephrol 7:110\u2013115","journal-title":"Am J Nephrol"},{"key":"5126_CR53","doi-asserted-by":"publisher","first-page":"614","DOI":"10.7326\/0003-4819-115-8-614","volume":"115","author":"DR Powars","year":"1991","unstructured":"Powars DR, Elliott-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, Johnson C (1991) Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med 115:614\u2013620","journal-title":"Ann Intern Med"},{"key":"5126_CR54","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2369-14-237","volume":"14","author":"P Bodas","year":"2013","unstructured":"Bodas P, Huang A, O\u2019Riordan MA, Sedor JR, Dell KM (2013) The prevalence of hypertension and abnormal kidney function in children with sickle cell disease -a cross sectional review. BMC Nephrol 14:2\u20137","journal-title":"BMC Nephrol"},{"key":"5126_CR55","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/01.md.0000189089.45003.52","volume":"84","author":"DR Powars","year":"2005","unstructured":"Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C (2005) Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore) 84:363\u2013376","journal-title":"Medicine (Baltimore)"},{"key":"5126_CR56","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.kint.2016.09.051","volume":"91","author":"EA Burdmann","year":"2017","unstructured":"Burdmann EA, Jha V (2017) Acute kidney injury due to tropical infectious diseases and animal venoms: a tale of 2 continents. Kidney Int 91:1033\u20131046","journal-title":"Kidney Int"},{"key":"5126_CR57","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s12936-016-1516-y","volume":"15","author":"ME Van Wolfswinkel","year":"2016","unstructured":"Van Wolfswinkel ME, Koopmans LC, Hesselink DA, Hoorn EJ, Koelewijn R, Van Hellemond JJ, Van Genderen PJJ (2016) Neutrophil gelatinase-associated lipocalin (NGAL) predicts the occurrence of malaria-induced acute kidney injury. Malar J 15:464","journal-title":"Malar J"},{"key":"5126_CR58","doi-asserted-by":"publisher","first-page":"964","DOI":"10.2215\/CJN.00590120","volume":"15","author":"A Amoura","year":"2020","unstructured":"Amoura A, Moktefi A, Halfon M, Karras A, Rafat C, Gibier JB, Gleeson PJ, Servais A, Argy N, Maill\u00e9 P, Belenfant X, Gueutin V, Delpierre A, Tricot L, El Karoui K, Jourde-Chiche N, Houze S, Sahali D, Audard V (2020) Malaria, collapsing glomerulopathy, and focal and segmental glomerulosclerosis. Clin J Am Soc Nephrol 15:964\u2013972","journal-title":"Clin J Am Soc Nephrol"},{"key":"5126_CR59","doi-asserted-by":"publisher","first-page":"e734","DOI":"10.1097\/CCM.0000000000004469","volume":"48","author":"BJ Ouma","year":"2020","unstructured":"Ouma BJ, Ssenkusu JM, Shabani E, Datta D, Opoka RO, Idro R, Bangirana P, Park G, Joloba ML, Kain KC, John CC, Conroy AL (2020) Endothelial activation, acute kidney injury, and cognitive impairment in pediatric severe malaria. Crit Care Med 48:e734\u2013e743","journal-title":"Crit Care Med"},{"key":"5126_CR60","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1136\/bmj.2.5759.445","volume":"2","author":"A Adeloye","year":"1971","unstructured":"Adeloye A, Luzzatto L, Edington GM (1971) Severe malarial infection in a patient with sickle-cell anaemia. Br Med J 2:445\u2013446","journal-title":"Br Med J"},{"key":"5126_CR61","doi-asserted-by":"publisher","unstructured":"Oniyangi O, Omari AA (2019) Malaria chemoprophylaxis in sickle cell disease. Cochrane Database Syst Rev 2019. https:\/\/doi.org\/10.1002\/14651858.CD003489.pub2","DOI":"10.1002\/14651858.CD003489.pub2"},{"key":"5126_CR62","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.3324\/haematol.2014.120030","volume":"100","author":"S Tewari","year":"2015","unstructured":"Tewari S, Brousse V, Piel FB, Menzel S, Rees DC (2015) Environmental determinants of severity in sickle cell disease. Haematologica 100:1108\u20131116","journal-title":"Haematologica"},{"key":"5126_CR63","doi-asserted-by":"crossref","first-page":"e28006","DOI":"10.1002\/pbc.28006","volume":"67","author":"A Power-Hays","year":"2020","unstructured":"Power-Hays A, Li S, Mensah A, Sobota A (2020) Universal screening for social determinants of health in pediatric sickle cell disease: a quality-improvement initiative. Pediatr Blood Cancer 67:e28006","journal-title":"Pediatr Blood Cancer"},{"key":"5126_CR64","unstructured":"World health organisation. Social determinants of health. https:\/\/www.who.int\/health-topics\/socialdeterminants-of-health. Accessed 27 March 2021"},{"key":"5126_CR65","doi-asserted-by":"publisher","first-page":"e28202","DOI":"10.1002\/pbc.28202","volume":"67","author":"JL Raphael","year":"2020","unstructured":"Raphael JL (2020) Addressing social determinants of health in sickle cell disease: the role of Medicaid policy. Pediatr Blood Cancer 67:e28202","journal-title":"Pediatr Blood Cancer"},{"key":"5126_CR66","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1080\/17474086.2017.1395279","volume":"10","author":"RP Naik","year":"2017","unstructured":"Naik RP, Derebail VK (2017) The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait. Expert Rev Hematol 10:1087\u20131094","journal-title":"Expert Rev Hematol"},{"key":"5126_CR67","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1365-2141.2010.08269.x","volume":"150","author":"R Colombatti","year":"2010","unstructured":"Colombatti R, Maschietto N, Varotto E, Grison A, Grazzina N, Meneghello L, Teso S, Carli M, Milanesi O, Sainati L (2010) Pulmonary hypertension in sickle cell disease children under 10 years of age. Br J Haematol 150:601\u2013609","journal-title":"Br J Haematol"},{"key":"5126_CR68","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00467-011-1857-2","volume":"26","author":"B Aygun","year":"2011","unstructured":"Aygun B, Mortier NA, Smeltzer MP, Hankins JS, Ware RE (2011) Glomerular hyperfiltration and albuminuria in children with sickle cell anemia. Pediatr Nephrol 26:1285\u20131290","journal-title":"Pediatr Nephrol"},{"key":"5126_CR69","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/bjh.14724","volume":"178","author":"A Geard","year":"2017","unstructured":"Geard A, Pule GD, Chetcha Chemegni B, Ngo Bitoungui VJ, Kengne AP, Chimusa ER, Wonkam A (2017) Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon. Br J Haematol 178:629\u2013639","journal-title":"Br J Haematol"},{"key":"5126_CR70","doi-asserted-by":"crossref","unstructured":"Strumph K, Hafeman M, Ranabothu S, Gomes W, Benitez S, Kaskel F, Manwani D, Mahgerefteh J (2021) Nocturnal hypertension associated with stroke and silent cerebral infarcts in children with sickle cell disease. Pediatr Blood Cancer 68:e28883","DOI":"10.1002\/pbc.28883"},{"key":"5126_CR71","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jash.2018.04.005","volume":"12","author":"DG Moodalbail","year":"2018","unstructured":"Moodalbail DG, Falkner B, Keith SW, Mathias RS, Araya CE, Zaritsky JJ, Stuart MJ (2018) Ambulatory hypertension in a pediatric cohort of sickle cell disease. J Am Soc Hypertens 12:542\u2013550","journal-title":"J Am Soc Hypertens"},{"key":"5126_CR72","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00467-012-2275-9","volume":"28","author":"IF Shatat","year":"2013","unstructured":"Shatat IF, Jakson SM, Blue AE, Johnson MA, Orak JK, Kalpatthi R (2013) Masked hypertension is prevalent in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol 28:115\u2013120","journal-title":"Pediatr Nephrol"},{"key":"5126_CR73","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/pbc.24843","volume":"61","author":"AM Becker","year":"2014","unstructured":"Becker AM, Goldberg JH, Henson M, Ahn C, Tong L, Baum M, Buchanan GR (2014) Blood pressure abnormalities in children with sickle cell anemia. Pediatr Blood Cancer 61:518\u2013522","journal-title":"Pediatr Blood Cancer"},{"key":"5126_CR74","doi-asserted-by":"publisher","first-page":"e18863","DOI":"10.1371\/journal.pone.0018863","volume":"6","author":"MR Asnani","year":"2011","unstructured":"Asnani MR, Fraser RA, Reid ME (2011) Higher rates of hemolysis are not associated with albuminuria in Jamaicans with sickle cell disease. PLoS One 6:e18863","journal-title":"PLoS One"},{"key":"5126_CR75","doi-asserted-by":"publisher","first-page":"756","DOI":"10.2215\/CJN.08511109","volume":"5","author":"JP Haymann","year":"2010","unstructured":"Haymann JP, Stankovic K, Levy P, Avellino V, Tharaux PL, Letavernier E, Grateau G, Baud L, Girot R, Lionnet F (2010) Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature. Clin J Am Soc Nephrol 5:756\u2013761","journal-title":"Clin J Am Soc Nephrol"},{"key":"5126_CR76","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","volume":"330","author":"OS Platt","year":"1994","unstructured":"Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330:1639\u20131644","journal-title":"N Engl J Med"},{"key":"5126_CR77","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1681\/ASN.2002010084","volume":"17","author":"A Guasch","year":"2006","unstructured":"Guasch A, Navarrete J, Nass K, Zayas CF (2006) Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol 17:2228\u20132235","journal-title":"J Am Soc Nephrol"},{"key":"5126_CR78","first-page":"277","volume":"20","author":"SK Ballas","year":"2001","unstructured":"Ballas SK (2001) Effect of \u03b1-globin genotype on the pathophysiology of sickle cell disease. Pediatr Pathol Mol Med 20:277\u2013286","journal-title":"Pediatr Pathol Mol Med"},{"key":"5126_CR79","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1001\/jama.289.13.1645","volume":"289","author":"MH Steinberg","year":"2003","unstructured":"Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, Varma M, Ramirez G, Adler B, Smith W, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K, Waclawiw M, Bonds D, Terrin M (2003) Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. J Am Med Assoc 289:1645\u20131651","journal-title":"J Am Med Assoc"},{"key":"5126_CR80","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1681\/ASN.2016121322","volume":"29","author":"JFO Toole","year":"2018","unstructured":"Toole JFO, Schilling W, Kunze D, Madhavan SM, Konieczkowski M, Gu Y, Luo L, Wu Z, Bruggeman LA, Sedor JR (2018) ApoL1 overexpression drives variant-independent cytotoxicity. J Am Soc Nephrol 29:869\u2013879","journal-title":"J Am Soc Nephrol"},{"key":"5126_CR81","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.ekir.2019.04.002","volume":"4","author":"PM Ekulu","year":"2019","unstructured":"Ekulu PM, Nkoy AB, Betukumesu DK, Aloni MN, Makulo JRR, Sumaili EK, Mafuta EM, Elmonem MA, Arcolino FO, Kitetele FN, Lepira FB, van den Heuvel LP, Levtchenko EN (2019) APOL1 risk genotypes are associated with early kidney damage in children in sub-Saharan Africa. Kidney Int Rep 4:930\u2013938","journal-title":"Kidney Int Rep"},{"key":"5126_CR82","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","volume":"329","author":"G Genovese","year":"2010","unstructured":"Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329:841\u2013845","journal-title":"Science"},{"key":"5126_CR83","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1681\/ASN.2011040388","volume":"22","author":"JB Kopp","year":"2011","unstructured":"Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollak M, Winkler CA (2011) APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 22:2129\u20132137","journal-title":"J Am Soc Nephrol"},{"key":"5126_CR84","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00467-020-04553-z","volume":"36","author":"PM Ekulu","year":"2021","unstructured":"Ekulu PM, Nkoy AB, Adebayo OC, Kazadi OK, Aloni MN, Arcolino FO, Ngiyulu RM, Gini JLE, Lepira FB, Van den Heuvel LP, Levtchenko EN (2021) A focus on the association of Apol1 with kidney disease in children. Pediatr Nephrol 36:777\u2013788","journal-title":"Pediatr Nephrol"},{"key":"5126_CR85","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/bjh.14842","volume":"179","author":"R Kormann","year":"2017","unstructured":"Kormann R, Jannot AS, Narjoz C, Ribeil JA, Manceau S, Delville M, Joste V, Pri\u00e9 D, Pouchot J, Thervet E, Courbebaisse M, Arlet JB (2017) Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target. Br J Haematol 179:326\u2013335","journal-title":"Br J Haematol"},{"key":"5126_CR86","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1681\/ASN.2011010069","volume":"22","author":"SM Madhavan","year":"2011","unstructured":"Madhavan SM, O\u2019Toole JF, Konieczkowski M, Ganesan S, Bruggeman LA, Sedor JR (2011) APOL1 localization in normal kidney and nondiabetic kidney disease. J Am Soc Nephrol 22:2119\u20132128","journal-title":"J Am Soc Nephrol"},{"key":"5126_CR87","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1681\/ASN.2013091017","volume":"26","author":"L Ma","year":"2015","unstructured":"Ma L, Shelness GS, Snipes JA, Murea M, Antinozzi PA, Cheng D, Saleem MA, Satchell SC, Banas B, Mathieson PW, Kretzler M, Hemal AK, Rudel LL, Petrovic S, Weckerle A, Pollak MR, Ross MD, Parks JS, Freedman BI (2015) Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines. J Am Soc Nephrol 26:339\u2013348","journal-title":"J Am Soc Nephrol"},{"key":"5126_CR88","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1016\/j.celrep.2020.02.064","volume":"30","author":"S Uzureau","year":"2020","unstructured":"Uzureau S, Lecordier L, Uzureau P, Hennig D, Graversen JH, Hombl\u00e9 F, Mfutu PE, Oliveira Arcolino F, Ramos AR, La Rovere RM, Luyten T, Vermeersch M, Tebabi P, Dieu M, Cuypers B, Deborggraeve S, Rabant M, Legendre C, Moestrup SK, Levtchenko E, Bultynck G, Erneux C, P\u00e9rez-Morga D, Pays E (2020) APOL1 C-terminal variants may trigger kidney disease through interference with APOL3 control of actomyosin. Cell Rep 30:3821-3836.e13","journal-title":"Cell Rep"},{"key":"5126_CR89","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1089\/ars.2016.6659","volume":"25","author":"JM Lever","year":"2016","unstructured":"Lever JM, Boddu R, George JF, Agarwal A (2016) Heme oxygenase-1 in kidney health and disease. Antioxid Redox Signal 25:165\u2013183","journal-title":"Antioxid Redox Signal"},{"key":"5126_CR90","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1172\/JCI112013","volume":"76","author":"S Anderson","year":"1985","unstructured":"Anderson S, Meyer TW, Rennke HG, Brenner BM (1985) Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76:612\u2013619","journal-title":"J Clin Invest"},{"key":"5126_CR91","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1056\/NEJM199204023261402","volume":"326","author":"RJ Falk","year":"1992","unstructured":"Falk RJ, Scheinman J, Phillips G, Orringer E, Johnson A, Jennette JC (1992) Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med 326:910\u2013915","journal-title":"N Engl J Med"},{"key":"5126_CR92","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/pbc.20296","volume":"45","author":"CD Fitzhugh","year":"2005","unstructured":"Fitzhugh CD, Wigfall DR, Ware RE (2005) Enalapril and hydroxyurea therapy for children with sickle nephropathy. Pediatr Blood Cancer 45:982\u2013985","journal-title":"Pediatr Blood Cancer"},{"key":"5126_CR93","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0002-9343(99)80341-6","volume":"98","author":"RY Aoki","year":"1995","unstructured":"Aoki RY, Saad STO (1995) Enalapril reduces the albuminuria of patients with sickle cell disease. Am J Med 98:432\u2013435","journal-title":"Am J Med"},{"key":"5126_CR94","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/MPH.0b013e3180335081","volume":"29","author":"KT McKie","year":"2007","unstructured":"McKie KT, Hanevold CD, Hernandez C, Waller JL, Ortiz L, McKie KM (2007) Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease. J Pediatr Hematol Oncol 29:140\u2013144","journal-title":"J Pediatr Hematol Oncol"},{"key":"5126_CR95","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","volume":"332","author":"S Charache","year":"1995","unstructured":"Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 332:1317\u20131322","journal-title":"N Engl J Med"},{"key":"5126_CR96","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/pbc.20645","volume":"47","author":"O Alvarez","year":"2006","unstructured":"Alvarez O, Montane B, Lopez G, Wilkinson J, Miller T (2006) Early blood transfusions protect against microalbuminuria in children with sickle cell disease. Pediatr Blood Cancer 47:71\u201376","journal-title":"Pediatr Blood Cancer"},{"key":"5126_CR97","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/ki.1985.70","volume":"27","author":"PE De Jong","year":"1985","unstructured":"De Jong PE, Van Eps LWS (1985) Sickle cell nephropathy: new insights into its pathophysiology. Kidney Int 27:711\u2013717","journal-title":"Kidney Int"},{"key":"5126_CR98","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00467-010-1536-8","volume":"25","author":"LJ Becton","year":"2010","unstructured":"Becton LJ, Kalpatthi RV, Rackoff E, Disco D, Orak JK, Jackson SM, Shatat IF (2010) Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease. Pediatr Nephrol 25:1505\u20131511","journal-title":"Pediatr Nephrol"},{"key":"5126_CR99","first-page":"130","volume":"2","author":"BA Warady","year":"1998","unstructured":"Warady BA, Sullivan EK (1998) Renal transplantation in children with sickle cell disease: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 2:130\u2013133","journal-title":"Pediatr Transplant"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05126-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-021-05126-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05126-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T08:50:30Z","timestamp":1699087830000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-021-05126-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,29]]},"references-count":99,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["5126"],"URL":"https:\/\/doi.org\/10.1007\/s00467-021-05126-4","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,29]]},"assertion":[{"value":"18 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}